Cambridge Heart, Inc. (NASDAQOTCBB:CAMH.OB)
CAPS Rating:
The Company is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease.
The Company is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease.